Psoriatic arthritis
- 1 January 2009
- journal article
- review article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 22 (1), 40-55
- https://doi.org/10.1111/j.1529-8019.2008.01215.x
Abstract
Although there is still some controversy about the existence of psoriatic arthritis (PsA) as a specific form of inflammatory arthritis associated with psoriasis, epidemiological and clinical studies support the unique features of PsA. Because of lack of diagnostic or classification criteria, the disease has been thought of as uncommon. New classification criteria should facilitate case definition of PsA. Over the past several decades, it has become clear that the disease leads to serious disability and even increased mortality. Traditional medications have not been effective in preventing the progression of joint damage. New medications, including biologics, have emerged with potential to controlling the inflammation and arresting the progression of joint damage.Keywords
This publication has 92 references indexed in Scilit:
- T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and PsoriasisJournal of Investigative Dermatology, 2008
- Predictors for radiological damage in psoriatic arthritis: results from a single centreAnnals Of The Rheumatic Diseases, 2007
- Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trialAnnals Of The Rheumatic Diseases, 2006
- Epidemiology of psoriatic arthritis in the population of the United StatesJournal of the American Academy of Dermatology, 2005
- Traditional and Newer Therapeutic Options for Psoriatic ArthritisDrugs, 2005
- HLA is a candidate region for psoriatic arthritis: evidence for excessive HLA sharing in sibling pairsHuman Immunology, 2003
- A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experienceRheumatology, 2003
- RANKL and RANK as novel therapeutic targets for arthritisCurrent Opinion in Rheumatology, 2003
- Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatmentAnnals Of The Rheumatic Diseases, 2002
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999